Search Results 1941-1950 of 16799 for CLL

  1. Mayo Clinic

    Management's Responsibility for the Financial Statements. Management is responsible for the preparation and fair presentation of these consolidated ...

  2. Publications - Thomas E. Kelly, Jr., M.D. - Mayo Clinic

    Wyatt RH, Shtull-Leber E, Kelly TE. Dysphagia Alone as a Unique Presentation of Wound Botulism in the Emergency Department: A Case Report.

  3. Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI - Mayo Clinic

    The purpose of this study is to find out if a PET/MR scan in combination with standard MRI and CT scans can improve the early detection and treatment of ...

  4. News - Biology of Aging and Age-Related Diseases Laboratory - Mayo Clinic Research

    Research in Dr. Jurk's Biology of Aging and Age-Related Diseases Lab is examining how senescence contributes to various diseases related to aging.

  5. A Study to Assess Feasibility and Benefit of a Patient-reported Outcomes Quality of Life Tool for Hematology and Medical Oncology - Mayo Clinic

    The purpose of this study is to determine the feasibility and benefit of a patient-reported outcomes quality of life tool for hematology and medical oncology.

  6. Mayo Clinic

    We are transforming healthcare! ... Make a gift now to help create new and better solutions for the more than 1.3 million patients who turn to Mayo Clinic each ...

  7. A Study to Evaluate TVB-2640 and Trastuzumab Plus Paclitaxel or Endocrine Therapy for Treating Patients with HER2 Positive Advanced Breast Cancer - Mayo Clinic

    FASN inhibitor TVB-2640 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as ...

  8. News - Brian E. Lacy, M.D., Ph.D. - Mayo Clinic

    Search for a doctor. Brian E. Lacy, M.D., Ph.D. Gastroenterologist; Neurogastroenterologist. Request an Appointment · Overview · News · Publications. News.

  9. Open-label, Multi-center, Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Autologous CAR-BCMA T-cells (CT053) in Patients

    Clinical Trials · Open-label, Multi-center, Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Autologous CAR-BCMA T-cells (CT053) in Patients.

  10. A Study of the Use of Computer Software for the Detection of Lung Diseases Over Time - Mayo Clinic

    About this study. The purpose of this study is to characterize lungs in normal healthy people without evidence of a pre-existing lung disease using computer ...